本页面由Tiger Trade Technology Pte. Ltd.提供服务

Olema Pharmaceuticals, Inc.

7.48
-0.3400-4.35%
成交量:34.44万
成交额:259.95万
市值:6.52亿
市盈率:-3.51
高:7.77
开:7.77
低:7.39
收:7.82
52周最高:36.26
52周最低:6.65
股本:8,715.70万
流通股本:7,188.81万
量比:0.86
换手率:0.48%
股息:- -
股息率:- -
每股收益(TTM):-2.1289
每股收益(LYR):-1.8700
净资产收益率:-52.74%
总资产收益率:-31.82%
市净率:1.51
市盈率(LYR):-4.00

数据加载中...

2026/08/13

重要事件披露

Form 8-K - Current report
2026/08/10

重要事件披露

Form 8-K - Current report
2026/08/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/06

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/30

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/23

重要事件披露

Form 8-K - Current report
2026/05/26

重要事件披露

Form 8-K - Current report
2026/05/22

重要事件披露

Form 8-K - Current report
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/12

重要事件披露

Form 8-K - Current report
2026/05/01

重要事件披露

Form 8-K - Current report
2026/04/29

重要事件披露

Form 8-K - Current report
2026/03/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/16

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/16

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]